BAP1 Tumor Predisposition Syndrome (BAP1-TPDS) is very rare, and its pattern was only recently classified in 2011. This syndrome is associated with several aggressive cancers...
Calciphylaxis was first seen in 1898, and later established in 1962 as a disease state involving calcification of multiple organs resulting in tissue death (necrosis). In humans it is most commonly seen in patients...
The National Psoriasis Foundation Task Force met to update the guidance for the management of psoriatic disease in the context of the COVID-19 pandemic...
Happy Clinical Trials Day!! The Menter Dermatology Research Institute would like to take this opportunity to thank all of our current and past trial participants...
We have been fortunate to participate in a study with Boehringer-Ingelheim using an IL-36 inhibitor for palmoplantar pustulosis (PPP)...
Ixekizumab (Taltz or IXE) is one of the newer anti-IL-17 antibodies available to patient as an injectable biologic medication. We looked into patient’s adherence, preferences and satisfaction in those treated with this medication.....
The more you know about living with psoriasis, the better equipped you’ll be to manage your psoriasis. Watch a series of videos for expert insights from dermatologist Dr. Alan Menter...
A special tribune video honoring Dr. Menter was presented at the Gala with spokepersons including Dr. Kenneth Gordon, Dr. Bruce Strober, Roger Staubach ...
Increased cardiovascular events in patient with psoriasis means management of this disease could be even more important...
Dr. Lawrence Green speaks about biologic therapy during the COVID-19 pandemic, answering a common question our patients also have...
